RecruitingNCT01106794
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Sponsor
Children's National Research Institute
Enrollment
100 participants
Start Date
Apr 1, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at autopsy, in order to characterize the molecular abnormalities of this tumor.
Eligibility
Max Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This study collects and analyzes tumor samples from patients with brainstem gliomas (brain tumors located in the brainstem) to understand the molecular makeup of these cancers and find better treatment targets.
**You may be eligible if...**
- You have been diagnosed with diffuse intrinsic pontine glioma (DIPG), a type of brainstem tumor, at any age
- You have another type of high-grade (aggressive) glioma originating in the brainstem
- You have a low-grade (slower-growing) focal glioma of the brainstem
**You may NOT be eligible if...**
- Your brain tumor started outside the brainstem (even if it spread there)
- You have a brainstem tumor of a different cell type (e.g., primitive neuroectodermal tumor)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01106794
Related Trials
Study of Olutasidenib and Temozolomide in HGG
NCT0616197420 locations
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
NCT0646519910 locations
Targeted Pediatric High-Grade Glioma Therapy
NCT0583937921 locations
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
NCT0584325320 locations
A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma
NCT075892571 location